Operating Lease, Right-of-Use Asset of Ernexa Therapeutics Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ernexa Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Ernexa Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $541,000, a 25% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Ernexa Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $541,000 -$178,000 -25% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $581,000 -$35,409,000 -98% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $619,000 -$35,905,000 -98% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $670,000 -$32,111,000 -98% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $719,000 -$34,141,000 -98% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $35,990,000 +$633,000 +1.8% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $36,524,000 +$35,535,000 +3593% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $32,781,000 +$31,751,000 +3083% 31 Dec 2023 10-K 12 Mar 2025 2024 FY
Q3 2023 $34,860,000 +$32,948,000 +1723% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $35,357,000 +$35,357,000 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $989,000 -$411,000 -29% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,030,000 -$1,537,000 -60% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $1,912,000 -$753,828 -28% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $0 -$2,767,804 -100% 30 Jun 2022 10-K 20 Mar 2023 2022 FY
Q1 2022 $1,400,000 -$623,263 -31% 31 Mar 2022 10-K 14 Mar 2024 2023 FY
Q4 2021 $2,567,000 +$474,000 +23% 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 $2,665,828 +$2,660,828 +53217% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $2,767,804 +$2,723,804 +6190% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $2,023,263 +$21,263 +1.1% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $2,093,000 -$8,000 -0.38% 31 Dec 2020 10-K/A 01 Jul 2022 2021 FY
Q3 2020 $5,000 -$2,171,000 -100% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $44,000 -$2,201,000 -98% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $2,002,000 -$262,000 -12% 31 Mar 2020 10-Q 20 May 2020 2020 Q1
Q4 2019 $2,101,000 -$199,000 -8.7% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $2,176,000 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $2,245,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $2,264,000 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 $2,300,000 31 Dec 2018 10-K 22 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.